RA CAPITAL MANAGEMENT L.P. 13D/13G Filings for LENZ Therapeutics, Inc. (LENZ)

RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for LENZ Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-07
4:47 pm
Purchase
2025-11-0513DLENZ Therapeutics, Inc.
LENZ
RA CAPITAL MANAGEMENT L.P.4,265,106
13.600%
4,500increase
(+0.11%)
Filing
2025-05-09
4:19 pm
Purchase
2025-05-0713DLENZ Therapeutics, Inc.
LENZ
RA CAPITAL MANAGEMENT L.P.4,260,606
15.100%
4,260,606increase
(New Position)
Filing